Your browser doesn't support javascript.
loading
A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial.
Hertz, T; Logan, M G; Rolland, M; Magaret, C A; Rademeyer, C; Fiore-Gartland, A; Edlefsen, P T; DeCamp, A; Ahmed, H; Ngandu, N; Larsen, B B; Frahm, N; Marais, J; Thebus, R; Geraghty, D; Hural, J; Corey, L; Kublin, J; Gray, G; McElrath, M J; Mullins, J I; Gilbert, P B; Williamson, C.
Afiliação
  • Hertz T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Logan MG; Division of Medical Virology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa.
  • Rolland M; Henry M. Jackson Foundation, U.S. Military HIV Research Program, Bethesda, MD 20817, United States.
  • Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Rademeyer C; Division of Medical Virology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa.
  • Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Edlefsen PT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • DeCamp A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Ahmed H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Ngandu N; Division of Medical Virology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa.
  • Larsen BB; Department of Microbiology, University of Washington, Seattle, WA, United States.
  • Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Marais J; Division of Medical Virology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa.
  • Thebus R; Division of Medical Virology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town 7925, South Africa.
  • Geraghty D; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Kublin J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Gray G; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • McElrath MJ; South African Medical Research Council, Cape Town, South Africa.
  • Mullins JI; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, United States.
  • Williamson C; Department of Microbiology, University of Washington, Seattle, WA, United States.
Vaccine ; 34(47): 5792-5801, 2016 11 11.
Article em En | MEDLINE | ID: mdl-27756485
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Produtos do Gene gag do Vírus da Imunodeficiência Humana / Produtos do Gene nef do Vírus da Imunodeficiência Humana / Imunidade Ativa Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Vacinas contra a AIDS / Produtos do Gene gag do Vírus da Imunodeficiência Humana / Produtos do Gene nef do Vírus da Imunodeficiência Humana / Imunidade Ativa Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos